Showing results (111-120 of 1,072) with videos related to
Sort By:
Pageof 108
Expert Review of Cardiovascular Therapy|July 1, 2011
Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitusDominick J Angiolillo, Marco Roffi, Antonio Fernandez-OrtizExpert Review of Cardiovascular Therapy|April 22, 2009
Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary interventionPiera Capranzano, Jose Luis Ferreiro, Dominick J AngiolilloExpert Review of Cardiovascular Therapy|October 10, 2009
Cangrelor: a review on its mechanism of action and clinical developmentJosé Luis Ferreiro, Masafumi Ueno, Dominick J AngiolilloEuropean Heart Journal|September 7, 2011
Current concepts on coronary revascularization in diabetic patientsMarco Roffi, Dominick J Angiolillo, A Pieter KappeteinFuture Cardiology|June 2, 2011
Antiplatelet drug therapy: role of pharmacodynamic and genetic testingAntonio Tello-Montoliu, Masafumi Ueno, Dominick J AngiolilloExpert Opinion on Investigational Drugs|October 29, 2010
Inhibiting PAR-1 in the prevention and treatment of atherothrombotic eventsSalvatore Davide Tomasello, Dominick J Angiolillo, Shinya GotoJournal of Cardiovascular Development and Disease|October 26, 2022
P2Y<sub>12</sub> Inhibitor Monotherapy after Percutaneous Coronary InterventionXuan Zhou, Dominick J Angiolillo, Luis Ortega-PazThe American Journal of Cardiology|November 22, 2012
Refining the role of antiplatelet therapy in medically managed patients with acute coronary syndromeWilliam E Boden, Alexandra Lansky, Dominick J AngiolilloExpert Opinion on Drug Metabolism & Toxicology|August 25, 2020
Clopidogrel drug interactions: a review of the evidence and clinical implicationsChang Hoon Lee, Francesco Franchi, Dominick J AngiolilloFuture Cardiology|July 9, 2010
Elinogrel: pharmacological principles, preclinical and early phase clinical testingMasafumi Ueno, Sunil V Rao, Dominick J AngiolilloPageof 108